1. Home
  2. Stocks
  3. Pghl Share Price

Procter & Gamble Health Share Price

Pharmaceuticals Mid Cap

₹5,544.05 +257.05 (4.86%)

05 Nov, 2024 16:53

SIP TrendupStart SIP in PGHL

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹5,494
  • High
  • ₹5,742
  • 52 Week Low
  • ₹4,637
  • 52 Week High
  • ₹5,742
  • Open Price₹5,584
  • Previous Close₹5,287
  • Volume128,499

Investment Returns

  • Over 1 Month + 4.05%
  • Over 3 Month + 4.61%
  • Over 6 Month + 16.7%
  • Over 1 Year + 7.91%
SIP Lightning

Smart Investing Starts Here Start SIP with Procter & Gamble Health for Steady Growth!

Procter & Gamble Health Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 42.3
  • PEG Ratio
  • -7.2
  • Market Cap Cr
  • 9,203
  • P/B Ratio
  • 17.1
  • Average True Range
  • 139.11
  • EPS
  • 129.6
  • Dividend Yield
  • 4.5
  • MACD Signal
  • -42.85
  • RSI
  • 56.22
  • MFI
  • 44.22

Procter & Gamble Health Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations313.41283.88252.48309.97304.93
Total Income From Operations313.41283.88252.48309.97304.93
P/L Before Interest, Excpt. Items & Tax111.5543.2262.8799.9188.23
P/L Before Exceptional Items & Tax111.4043.0262.7299.7288.05
P/L After Tax from Ordinary Activities82.3316.7846.5672.0765.57
Net Profit/Loss For the Period82.3316.7846.5672.0765.57
IndicatorJun 24Jun 23
Revenue From Operations [Gross]1,151.261,205.86
Revenue From Operations [Net]1,151.261,205.86
Total Operating Revenues1,151.261,229.62
Total Revenue1,166.891,248.01
Total Expenses873.38933.81
Profit/Loss Before Tax273.32314.20
Profit/Loss For The Period200.98229.47
IndicatorJun 23Jun 22
Net CashFlow - Operating Activity236.00169.52
Net Cash Used In Investing Activity-21.50-25.54
Net Cash Used in Finance Activity-98.48-288.63
Net Inc/Dec In Cash And Equivalent116.02-144.65
Cash And Equivalent End Of Year435.42319.40
IndicatorJun 24Jun 23
Total Share Capital16.6016.60
Total Non-Current Liabilities37.2146.40
Total Current Liabilities218.91303.90
Total Capital And Liabilities794.361,101.19
Total Non-Current Assets270.14305.09
Total Current Assets524.22796.10
Total Assets794.361,101.19
Indicator20242023
EBIT Margin (%)25.5525.61
Return On Capital Employed (%)51.1339.50
Return On Equity (%)37.3430.55
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)324.24452.34
Indicator20242023
EBIT Margin (%)25.5525.61
Return On Capital Employed (%)51.1339.50
Return On Equity (%)37.3430.55
Long Term Debt To Equity (%)0.000.00
Book Value/Share (INR)324.24452.34

Procter & Gamble Health Technicals

EMA & SMA

Current Price
₹5,544.05
+ 257.05 (4.86%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹5,176.43
  • 50 Day
  • ₹5,202.56
  • 100 Day
  • ₹5,168.52
  • 200 Day
  • ₹5,105.42

Resistance and Support

5299.82 Pivot Speed
  • R3 5,514.73
  • R2 5,447.37
  • R1 5,367.18
  • S1 5,219.63
  • S2 5,152.27
  • S3 5,072.08

Is Procter & Gamble Health Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

P&G Health is a leading global healthcare company specializing in consumer health products, including over-the-counter medications and dietary supplements. With a focus on innovation and quality, it aims to enhance the well-being of individuals and families worldwide. Procter & Gamble Health has an operating revenue of Rs. 1,151.26 Cr. on a trailing 12-month basis. An annual revenue de-growth of -6% needs improvement, Pre-tax margin of 24% is great, ROE of 37% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around -0% and 3% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 5% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 41 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Procter & Gamble Health Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-04 Quarterly Results
2024-08-21 Audited Results & Final Dividend
2024-05-02 Quarterly Results
2024-02-06 Quarterly Results & Interim Dividend
2023-11-03 Quarterly Results
Date Purpose Remarks
2024-02-14 INTERIM Rs.50.00 per share(500%)Interim Dividend
2024-02-14 SPECIAL Rs.150.00 per share(1500%)Special Dividend
2023-02-13 INTERIM Rs.45.00 per share(450%)Interim Dividend
2022-05-13 INTERIM Rs.41.00 per share(410%)Interim Dividend

Procter & Gamble Health F&O

Procter & Gamble Health Shareholding Pattern

51.82%
10.45%
4.09%
6.61%
0%
21.46%
5.57%
  • NSE Symbol
  • PGHL
  • BSE Symbol
  • 500126
  • Managing Director
  • Mr. Milind Thatte
  • ISIN
  • INE199A01012

Procter & Gamble Health FAQs

Procter & Gamble Health share price is ₹5,544 As on 05 November, 2024 | 16:39

The Market Cap of Procter & Gamble Health is ₹9202.8 Cr As on 05 November, 2024 | 16:39

The P/E ratio of Procter & Gamble Health is 42.3 As on 05 November, 2024 | 16:39

The PB ratio of Procter & Gamble Health is 17.1 As on 05 November, 2024 | 16:39

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.